Medical Doctor Program year 2025 Reported 2024–2025 Source: CMS Open Payments, 2026 publication

Evesha Kenlyn

Pain Medicine Atlanta, GA Medical Doctor

NPI 1477012656 CMS profile 11647525

49 Jesse Hill Jr Dr Se, Atlanta, GA 30303

Open in the dashboard

General payments

$8,741

86 records reported · program years 2024–2025

Research payments

$0

Paid to them · None reported · program years 2024–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Evesha Kenlyn of Atlanta, GA is reported in the CMS Open Payments database as having received $8,741 across 86 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,070 63
2024 General $3,672 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Evesha Kenlyn
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Evesha Kenlyn were reported at $5,070. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Evesha Kenlyn Pain Medicine median Middle half National median
2019 $0 $498 $126–$1,682 $163
2020 $0 $284 $80–$910 $114
2021 $0 $399 $112–$1,219 $132
2022 $0 $455 $137–$1,484 $149
2023 $0 $484 $128–$1,495 $160
2024 $3,672 $498 $131–$1,540 $164
2025 $5,070 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2024–2025
  1. Saluda Medical Americas, Inc. $2,505 14 payments
  2. BIOTRONIK NRO, Inc. $2,073 20 payments
  3. Boston Scientific Corporation $1,529 9 payments
  4. Spinal Simplicity, LLC $1,401 4 payments
  5. MML US, Inc. $233 5 payments
  6. Nevro Corp. $220 4 payments
  7. Globus Medical, Inc. $201 6 payments
  8. Curonix LLC $116 2 payments
  9. Abbott Laboratories $80 1 payment
  10. Foundation Fusion Solutions, LLC $67 6 payments
  11. Other $318 15 payments

Every payment, record by record

What the payments were for General payments · program years 2024–2025
  1. Travel and Lodging $5,052 14 payments
  2. Food and Beverage $3,689 72 payments
Products named General payments · program years 2024–2025
  1. Evoke $2,505 14 payments
  2. Prospera $1,457 17 payments
  3. HA MINUTEMAN G3-R $1,401 4 payments
  4. Intracept $766 2 payments
  5. LIBERTY SI $596 2 payments
  6. ReActiv8 $233 5 payments
  7. Senza Spinal Cord Stimulator $220 4 payments
  8. Senza Spinal Cord Stimulator $201 6 payments
  9. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $116 2 payments
  10. ETERNA $80 1 payment
  11. Other $395 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

25

Median for Internal Medicine: 777

Drug cost

$320

Median for Internal Medicine: $73,373

Branded share of claims

48%

Median for Internal Medicine: 19.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 12 $266
Gabapentin Generic 13 $54

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 27 billing codes

Paid by Medicare

$23,897

Medicare's payments for the services billed

Medicare patients

59

Average age 75

Services billed

606

42 women, 17 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Chronic kidney disease 32%
Diabetes 31%
Ischemic heart disease 29%
Depression 22%
COPD 20%
Atrial fibrillation 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ZTLido
  • Scilex Pharmaceuticals Inc. $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record